ea0037gp.19.06 | Pituitary–Acromegaly | ECE2015
Prencipe Nunzia
, Bona Chiara
, Karamouzis Joannis
, Berton Alessandro Maria
, Di Giacomo Stellina Valentina
, Guaraldi Federica
, Ghigo Ezio
, Grottoli Silvia
Acromegaly is due to increased GH secretion usually sustained by a GH-secreting pituitary adenoma. Somatostatin analogues (SSA) can control GH hypersecretion in 60% of patients and tumor volume in 30%. The disease control is, in turn, associated with lower mortality and therefore to verify the optimal control of the disease activity is of critical importance to adapt the dose and the choice of alternative treatment. The criteria for optimized disease control had been assumed a...